BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11436168)

  • 1. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
    Prayson RA
    Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastomas in Ibadan Nigeria: II--Clinicopathologic features.
    Akang EE; Ajaiyeoba IA; Campbell OB; Olurin IO; Aghadiuno PU
    West Afr J Med; 2000; 19(1):6-11. PubMed ID: 10821078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary fibrous tumor of the central nervous system: a clinicopathologic study of 24 cases.
    Chen H; Zeng XW; Wu JS; Dou YF; Wang Y; Zhong P; Xu R; Jiang CC; Wang XQ
    Acta Neurochir (Wien); 2012 Feb; 154(2):237-48; discussion 248. PubMed ID: 21938461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry.
    Prayson RA
    Am J Clin Pathol; 1996 Jun; 105(6):719-26. PubMed ID: 8659446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic and proliferative markers in chordomas: a study of 26 tumors.
    Kilgore S; Prayson RA
    Ann Diagn Pathol; 2002 Aug; 6(4):222-8. PubMed ID: 12170453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
    Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
    Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory neuroblastoma and other round cell lesions of the sinonasal region.
    Devaney K; Wenig BM; Abbondanzo SL
    Mod Pathol; 1996 Jun; 9(6):658-63. PubMed ID: 8782204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study on retinoblastoma cases attending a medical college in Calcutta.
    Mukhopadhyay S; Ghosh S; Chattopadhyay D; Dutta SK
    J Indian Med Assoc; 2006 Feb; 104(2):67-70. PubMed ID: 16856584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary osteosarcoma with rosette-like structure in a patient with retinoblastoma.
    Okada K; Hasegawa T; Tateishi U; Itoi E
    Virchows Arch; 2004 Oct; 445(4):421-4. PubMed ID: 15480771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms.
    Prayson RA; Suh JH
    Arch Pathol Lab Med; 1999 Apr; 123(4):306-9. PubMed ID: 10320142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
    Costa MJ; Walls J; Ames P; Roth LM
    Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.